The approved capital increase is a near-term dilutive event for HEPS shareholders, coming on the heels of a deteriorating financial profile (net loss doubling, EBITDA down 58%). Monitor the company's next filing for the specific terms and size of the capital raise, as the lack of disclosed details creates uncertainty. The stock may face downward pressure as the market prices in dilution risk.
Price Chart
Executive Summary
Hepsiburada (HEPS) announced via 6-K that shareholders at the Extraordinary General Assembly held August 14, 2026, approved an increase in the company's total share capital and related amendments to the Articles of Association. This capital increase follows the change of control to Kaspi.kz and comes against a backdrop of widening net losses and material weaknesses in internal controls reported in the 2025 annual report. The approval is a procedural step toward executing the capital raise, which is likely dilutive to existing shareholders, though the specific size and terms remain undisclosed.
Key Facts
- Shareholders approved an increase in the company's total share capital at the EGM on August 14, 2026.
- The capital increase will involve amending Article 6 of the company's Articles of Association titled 'Capital'.
- The company's 2025 annual report (20-F) showed a net loss of TRY 5,699.2 million, widening from a TRY 2,100.7 million loss in 2024.
- Revenue grew 13.4% to TRY 84.7 billion, but EBITDA fell 57.8% to TRY 1,141.4 million.
- The filing confirms the change of control to Kaspi.kz and ongoing material weaknesses in internal controls.
Financial Impact
Share capital increase approved; specific size and terms not disclosed. Dilution risk is present. Prior annual report showed net loss more than doubled to TRY 5,699.2 million.
Risk Factors
- Dilution from the approved share capital increase, the size of which is undisclosed.
- Widening net losses and declining EBITDA signal deteriorating operational health.
- Ongoing material weaknesses in internal controls increase execution and reporting risk.
- Change of control to Kaspi.kz introduces strategic uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-099021 |
| Document: tm2623591d1_ex99-1.htm | 0001104659-26-099021 |
| Document: 0001104659-26-099021-index-headers.html | 0001104659-26-099021 |
| Document: 0001104659-26-099021-index.html | 0001104659-26-099021 |
| Document: 0001104659-26-099021.txt | 0001104659-26-099021 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | Press Release | $2.48 | awaiting T+20 | — | $2.78 (+12.10%) |
Sep 9, 2026 6w ago | 6-K | $2.65 $2.65 | · 0.00% | ▼ −1.94% | $2.78 (+4.91%) |
Aug 20, 2026 9w ago | 6-K | $2.67 $2.50 | ▲ +6.37% | ▲ +6.37% | $2.78 (−4.12%) |
Aug 6, 2026 11w ago | Press Release | $2.77 $2.68 | ▲ +3.43% | ▲ +3.03% | $2.78 (−0.36%) |
Jul 23, 2026 13w ago | 6-K | $2.84 $2.67 | ▼ −5.99% | ▼ −9.29% | $2.78 (−2.11%) |
Jul 14, 2026 14w ago | Press Release | $2.96 $2.84 | ▲ +4.05% | ▲ +6.40% | $2.78 (+6.08%) |
Jun 30, 2026 16w ago | 6-K | $2.91 $2.84 | ▼ −2.41% | ▼ −1.38% | $2.78 (−4.47%) |
Apr 30, 2026 25w ago | 20-F | $2.80 $2.78 | ▲ +0.71% | ▲ +5.98% | $2.78 (+0.71%) |
Apr 16, 2026 27w ago | Press Release | $2.80 $2.59 | ▼ −7.50% | ▼ −12.87% | $2.78 (−0.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers